Effects of Rosiglitazone/PHBV Drug Delivery System on Postoperative Fibrosis in Rabbit Glaucoma Filtration Surgery Model
Overview
Affiliations
The aim of this study is to investigate the effects and toxicities of poly(3-hydroxybutyric acid--3-hydroxyvaleric acid) (PHBV)-loading rosiglitazone on preventing scar formation after glaucoma filtration surgery (GFS) in the rabbit model. Rosiglitazone/PHBV drug delivery system was prepared via electrospinning. Release behavior of RSG/PHBV membrane was evaluated by high-performance liquid chromatography. The different concentration membranes were implanted under the conjunctiva of the rabbit's eyes (RSG/PHBV groups). Also, MMC-soaked sponges were placed under the conjunctiva of the eyes (positive group) for 3 min. Intraocular pressures and bleb features were then assessed for 4 weeks postoperative. Bleb sections were stained with HE, Masson's trichrome and α smooth muscle action (αSMA) immunohistochemistry. The protein expression of collagen I, αSMA, and connective tissue growth factor in the bleb area were then quantified. The following results were observed: (1) the concentration of rosiglitazone would not affect the morphology of RSG/PHBV membrane. (2) RSG/PHBV membrane would effective and safety prevent the formation of fibrosis after GFS in the rabbit model. Implantation of RSG/PHBV membrane prevents scar formation after GFS. What's more, it ameliorated toxicity to conjunctiva and cornea compared with the placement of MMC. The RSG/PHBV membrane would be a more effectivity and safer strategy than MMC.
Zhou D, Zhu W, Liu H, Zhang F, Zhou X, Zhang X Mater Today Bio. 2024; 24:100922.
PMID: 38226011 PMC: 10788518. DOI: 10.1016/j.mtbio.2023.100922.
Quercetin modified electrospun PHBV fibrous scaffold enhances cartilage regeneration.
Chen W, Li Y, Huang Y, Dai Y, Xi T, Zhou Z J Mater Sci Mater Med. 2021; 32(8):92.
PMID: 34374884 PMC: 8354921. DOI: 10.1007/s10856-021-06565-z.
Oouchi Y, Watanabe M, Ida Y, Ohguro H, Hikage F Int J Mol Sci. 2021; 22(14).
PMID: 34298955 PMC: 8307967. DOI: 10.3390/ijms22147335.
Ma X, Liu L Mol Med Rep. 2021; 23(3).
PMID: 33495826 PMC: 7821338. DOI: 10.3892/mmr.2021.11843.
Chen H, Qian Z, Zhang S, Tang J, Le Fang , Jiang F Redox Biol. 2020; 38:101774.
PMID: 33152664 PMC: 7645269. DOI: 10.1016/j.redox.2020.101774.